About this data
What it is
The FDA publishes its decisions on drugs and medical devices through openFDA. We list approved drug applications and the changes approved to them, 510(k) clearances of devices and premarket approvals (PMA) of higher-risk devices, and match the applicant to a public company when the name lines up. The page opens on new brand-name drugs and biologics: the first approval of a new drug application (NDA) or biologics license application (BLA).
Who files it
The FDA decides; openFDA publishes the FDA's records. The applicant is the company named in the FDA's record for the application.
How current
We check openFDA every day. The FDA refreshes its files on its own schedule, and a decision can appear days to weeks after its date, so the latest approvals may show up late.
Terms
openFDAopenFDA is the FDA's public data service. It publishes the FDA's own records of drug approvals and device decisions. openFDA asks users not to imply that the FDA endorses their product or service: this site is not endorsed by or affiliated with the FDA.NDA and BLAA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original.supplementA later approved change to a drug that is already on the market: a new use, a new dose, a label change or a manufacturing change. Many supplements are minor.generic drugsA generic drug (an ANDA, or abbreviated new drug application) is approved because it matches a drug already on the market. Generics are made by many companies, most of which are not public.510(k)A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval.PMAPremarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.company matchWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.
Worth knowing
This is a record of decisions already made. It is not a calendar of coming decisions: a drug under review does not appear, and we show no review dates. openFDA asks users not to imply that the FDA endorses their product or service: this page is not endorsed by or affiliated with the FDA, and the FDA makes no warranty about the data. It is not for medical decisions. Most applicants, such as generic makers and private device makers, do not match a public company, and a subsidiary or a differently spelled name can be missed, so a row with no ticker may still belong to one. A clearance is not an approval, and many approved supplements are minor.
Not to be confused with
Clinical trial updates: what sponsors report about their studies, not what the FDA decided.

All of this comes from openFDA, the FDA's public data service. This site is not endorsed by or affiliated with the FDA.

FDA decisions per day, last 30 days

010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0
010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0

Brand-name drugs and biologics, with supplements Device clearances and approvals

By the FDA's decision date. Generic drugs are left out. The FDA's files can lag a decision by days to weeks, so the most recent days fill in later.

Latest FDA decisions

Reset

Showing: ticker VTRS · Everything

Latest FDA decisions
DecidedProductApplicantWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.DecisionA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original. A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval. Premarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.FDA page
Oct 14, 2026DIPENTUM
OLSALAZINE SODIUM
VTRS
Mylan Spclt Viatris
New drug (NDA), supplement
Labeling
NDA019715 ↗
Oct 14, 2026MESALAMINE, ROWASA
MESALAMINE
VTRS
Mylan Speciality LP
New drug (NDA), supplement
Labeling
NDA019618 ↗
Oct 14, 2026VALACYCLOVIR HYDROCHLORIDE
VALACYCLOVIR HYDROCHLORIDE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA078518 ↗
Oct 8, 2026CARBIDOPA AND LEVODOPA
CARBIDOPA; LEVODOPA
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA075091 ↗
Oct 7, 2026AMNESTEEM
ISOTRETINOIN
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
REMS
ANDA075945 ↗
Oct 2, 2026CLOZAPINE
CLOZAPINE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA075417 ↗
Oct 2, 2026CLOZAPINE
CLOZAPINE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA075417 ↗
Oct 2, 2026CLOZAPINE
CLOZAPINE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA075417 ↗
Sep 30, 2026INDOMETHACIN
INDOMETHACIN
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA202139 ↗
Sep 23, 2026SPIRONOLACTONE
SPIRONOLACTONE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA040424 ↗
Sep 15, 2026AMNESTEEM
ISOTRETINOIN
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA075945 ↗
Sep 1, 2026NEVIRAPINE
NEVIRAPINE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA205651 ↗
Aug 21, 2026AMNESTEEM
ISOTRETINOIN
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA075945 ↗
Aug 14, 2026BUPRENORPHINE AND NALOXONE
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
VTRS
Mylan Technologies
Generic (ANDA), supplement
REMS
ANDA211785 ↗
Aug 14, 2026BUPRENORPHINE AND NALOXONE
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
VTRS
Mylan Technologies
Generic (ANDA), supplement
REMS
ANDA207607 ↗
Aug 11, 2026SAXAGLIPTIN AND METFORMIN
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA205981 ↗
Aug 11, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA200690 ↗
Aug 11, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA075973 ↗
Aug 10, 2026SCOPOLAMINE
SCOPOLAMINE
VTRS
Mylan Technologies
Generic (ANDA), supplement
Labeling
ANDA203753 ↗
Aug 10, 2026SCOPOLAMINE
SCOPOLAMINE
VTRS
Mylan Technologies
Generic (ANDA), supplement
Labeling
ANDA203753 ↗
Aug 7, 2026FOSAPREPITANT
FOSAPREPITANT DIMEGLUMINE
VTRS
Mylan Labs Ltd
Generic (ANDA), supplement
Labeling
ANDA204015 ↗
Aug 5, 2026FENOFIBRATE
FENOFIBRATE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA204475 ↗
Aug 4, 2026SAXAGLIPTIN AND METFORMIN
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA205981 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
VTRS
Mylan Labs Ltd
Generic (ANDA), supplement
REMS
ANDA203859 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
VTRS
Mylan
Generic (ANDA), supplement
REMS
ANDA065521 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
VTRS
Mylan
Generic (ANDA), supplement
REMS
ANDA065520 ↗
Jul 28, 2026GWYN LO
ETHINYL ESTRADIOL; NORELGESTROMIN
VTRS
Viatris Specialty
New drug (NDA)
Type 5 - New Formulation or New Manufac…
NDA219990 ↗
Jul 28, 2026SUGAMMADEX
SUGAMMADEX SODIUM
VTRS
Mylan
Generic (ANDA)
UNKNOWN
ANDA213915 ↗
Jul 22, 2026METHYLPHENIDATE
METHYLPHENIDATE
VTRS
Mylan Tech Viatris
Generic (ANDA), supplement
Labeling
ANDA206497 ↗
Jul 22, 2026METHYLPHENIDATE
METHYLPHENIDATE
VTRS
Mylan Tech Viatris
Generic (ANDA), supplement
Labeling
ANDA206497 ↗
Jul 16, 2026DOXEPIN HYDROCHLORIDE
DOXEPIN HYDROCHLORIDE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA070791 ↗
Jun 26, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA200690 ↗
Jun 26, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
VTRS
Mylan Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA200690 ↗
Jun 25, 2026FERRIC CARBOXYMALTOSE
FERRIC CARBOXYMALTOSE
VTRS
Mylan
Generic (ANDA)
UNKNOWN
ANDA217769 ↗
Jun 25, 2026FERRIC CARBOXYMALTOSE
FERRIC CARBOXYMALTOSE
VTRS
Mylan
Generic (ANDA)
UNKNOWN
ANDA217076 ↗
Jun 25, 2026FERRIC CARBOXYMALTOSE
FERRIC CARBOXYMALTOSE
VTRS
Mylan Labs Ltd
Generic (ANDA)
UNKNOWN
ANDA212572 ↗
Jun 25, 2026AMLODIPINE AND ATORVASTATIN
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA200465 ↗
Jun 18, 2026BUPRENORPHINE
BUPRENORPHINE
VTRS
Mylan Tech Viatris
Generic (ANDA), supplement
REMS
ANDA210162 ↗
Jun 18, 2026TRAMADOL HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE
VTRS
Mylan
Generic (ANDA), supplement
REMS
ANDA205257 ↗
Jun 18, 2026FENTANYL
FENTANYL
VTRS
Mylan Technologies
Generic (ANDA), supplement
REMS
ANDA076258 ↗
Jun 15, 2026LIRAGLUTIDE
LIRAGLUTIDE
VTRS
Mylan Institutional
Generic (ANDA)
UNKNOWN
ANDA213155 ↗
Jun 12, 2026DIVALPROEX SODIUM
DIVALPROEX SODIUM
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA077567 ↗
Jun 8, 2026ESTRADIOL
ESTRADIOL
VTRS
Mylan Technologies
Generic (ANDA), supplement
Labeling
ANDA075182 ↗
Jun 8, 2026ESTRADIOL
ESTRADIOL
VTRS
Mylan Technologies
Generic (ANDA), supplement
Labeling
ANDA075182 ↗
Jun 8, 2026ESTRADIOL
ESTRADIOL
VTRS
Mylan Technologies
Generic (ANDA), supplement
Labeling
ANDA075182 ↗
May 27, 2026METHOTREXATE
METHOTREXATE SODIUM
VTRS
Mylan
Generic (ANDA), supplement
Labeling
ANDA081235 ↗
May 8, 2026LEVETIRACETAM IN SODIUM CHLORIDE
LEVETIRACETAM
VTRS
Mylan Labs Ltd
Generic (ANDA)
UNKNOWN
ANDA218364 ↗
May 7, 2026ACETAZOLAMIDE
ACETAZOLAMIDE SODIUM
VTRS
Mylan Asi
Generic (ANDA), supplement
Labeling
ANDA200880 ↗
Apr 27, 2026LENALIDOMIDE
LENALIDOMIDE
VTRS
Mylan
Generic (ANDA), supplement
REMS
ANDA213912 ↗
Apr 27, 2026POMALIDOMIDE
POMALIDOMIDE
VTRS
Mylan
Generic (ANDA), supplement
REMS
ANDA210275 ↗

The newest 50 items, most recent first. Each row links to the FDA's page for the application, clearance or approval. Updated Nov 15, 2026, 7:12 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates